My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Novavax, Inc. - Common Stock (NQ:NVAX)

7.780 -0.410 (-5.01%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

1 Beaten-Down Stock That's Still Not Worth Buying ↗

March 09, 2024

For this biotech, a rebound seems far too unlikely.

Via The Motley Fool

Three Stocks With The Potential For A Short Squeeze In March ↗

March 08, 2024

Short squeeze events are heralded by high short interest, trading volume spike, rapid stock price rise, and short interest ratio. Here are three stocks with the potential for a short squeeze in March.

Via Talk Markets

7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode ↗

March 07, 2024

Bullish speculators could have their opportunity to blow up the bears with these short-squeeze stocks to buy.

Via InvestorPlace

Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street ↗

March 07, 2024

Could these biotech companies still win in the vaccine market and beyond?

Via The Motley Fool

The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar ↗

March 06, 2024

Explore the ups and downs of 3 meme stocks: Imperial Petroleum, Novavax and MicroCloud, as they navigate market challenges and speculation.

Via InvestorPlace

Is Novavax a Buy Now? ↗

March 04, 2024

The stock has dropped 98% over the past three years.

Via The Motley Fool

Novavax's Earnings Outlook ↗

February 27, 2024

Via Benzinga

Has Novavax Just Solved Its Biggest Problem? ↗

February 27, 2024

The biotech company recently settled a dispute with a major customer.

Via The Motley Fool

Better Bull Market Buy: Novavax vs. Pfizer ↗

February 22, 2024

Bull markets usually favor stocks with promising growth prospects.

Via The Motley Fool

It’s Time! 3 Failing Biotech Stocks to Sell Right Now ↗

March 05, 2024

The biotech industry offers investors unique investment opportunities but these three are biotechs to sell.

Via InvestorPlace

Exit Alert: 3 Overhyped Stocks With Weak Fundamentals ↗

March 05, 2024

These are overhyped stocks to sell as they represent companies with weak fundamentals and prospects of cash burn.

Via InvestorPlace

1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock? ↗

March 01, 2024

Can the stock's recent rally continue?

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

February 29, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 28, 2024

Via Benzinga

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 28, 2024

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

Via Benzinga

Why Is Advance Auto Parts (AAP) Stock Trending Today? ↗

February 28, 2024

Advance Auto Parts stock is up on Wednesday even after posting EPS and revenue misses in its earnings report for the fourth quarter of 2023.

Via InvestorPlace

Why Is COVID-19 Vaccine Maker Novavax Stock Plunging On Wednesday? ↗

February 28, 2024

Novavax reports Q4 2023 revenue of $291 million, missing consensus. Restructuring brings 30% workforce reduction. Anticipates COVID-19-Influenza combo vaccine Phase 3 in H2 2024. FY 2024 revenue...

Via Benzinga

NVAX Stock Alert: 9 Reasons Why Novavax Investors Are So Disappointed Today ↗

February 28, 2024

Novavax stock is falling hard on Wednesday as NVAX investors react to it missing estimates for Q4 and posting weak guidance for 2024!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 28, 2024

Via Benzinga

Beyond Meat, Viking Therapeutics, Novavax, Baidu, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗

February 27, 2024

The U.S. indices were mixed with the S&P 500 rising by nearly 0.2% to 5,078.18 and the Dow Jones Industrial Average falling by 0.25% to 38,972.41.

Via Benzinga

Topics Stocks

Exploring Stocks with High Short Interest: INBS, BLNK, BYND, NVAX, PLUG

February 27, 2024

Via AB Newswire

Topics Electric Vehicles

Earnings Scheduled For February 28, 2024 ↗

February 28, 2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.

Via Benzinga

Novavax’s dispute resolution and upcoming earnings call

February 23, 2024

Novavax navigates legal settlements, earnings expectations, and competition, hoping their protein-based vaccines become a global health game-changer.

Via MarketBeat

Topics Earnings

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 22, 2024

Shares of Etsy, Inc.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 22, 2024

Via Benzinga

NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On Thursday ↗

February 22, 2024

U.S. stocks were higher, with the Nasdaq Composite gaining more 2% on Thursday.

Via Benzinga

Topics Stocks

Morgan Stanley Is Pounding the Table on DoorDash (DASH) Stock ↗

February 22, 2024

DoorDash stock is rising higher on Thursday after Morgan Stanley upgraded DASH shares and increased their price target for them.

Via InvestorPlace

Morgan Stanley Issues a Warning on Rivian (RIVN) Stock ↗

February 22, 2024

Rivian stock is falling hard on Friday as RIVN investors react to a warning from Morgan Stanley and a weak EV production guidance for 2024.

Via InvestorPlace

What's Going On With Novavax Stock Today? ↗

February 22, 2024

Novavax said it reached a settlement with Gavi related to the 2021 advance purchase agreement for Novavax's prototype COVID-19 vaccine. The agreement brings the pending arbitration related to the...

Via Benzinga

NVAX Stock Climbs as Novavax Settles Covid-19 Vaccine Dispute ↗

February 22, 2024

Novavax stock is climbing higher on Thursday as investors in NVAX shares react to it reaching a $475 million settlement with Gavi.

Via InvestorPlace

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.